New Therapies in Veterinary Oncology

Vet Clin North Am Small Anim Pract. 2024 May;54(3):469-476. doi: 10.1016/j.cvsm.2023.12.003. Epub 2024 Jan 6.

Abstract

The expanding number of specialized oncology therapeutics available in veterinary oncology can make staying updated on the most recent advances challenging. This article summarizes the mechanism of action, available supporting data, and clinical use of three key veterinary cancer/supportive care therapeutics: Laverdia-CA1, Canalevia-CA1, and Stelfonta. This information will help guide clinical use within your practice and can be incorporated into discussions with clients regarding the newest available options for their dogs with cancer.

Keywords: Canalevia; Laverdia; Novel therapy; Stelfonta.

Publication types

  • Review

MeSH terms

  • Animals
  • Dog Diseases* / therapy
  • Dogs
  • Humans
  • Medical Oncology
  • Neoplasms* / therapy
  • Neoplasms* / veterinary